Literature DB >> 19120292

IFN-alpha can both protect against and promote the development of type 1 diabetes.

F Susan Wong1, Li Wen.   

Abstract

Viral infection has been hypothesized to be one of the environmental triggers for the development of type 1 diabetes. Infection induces a large amount of interferon-alpha (IFN-alpha) produced by dendritic cells and other cells. To test the role of IFN-alpha in the development of diabetes, we have used three different experimental approaches in both diabetes-prone and -resistant animal models for type 1 diabetes. Our results suggested that a viral mimic or IFN-alpha can either suppress or promote the development of autoimmune diabetes, depending on the model system. It is likely that IFN-alpha plays a complex role in the etiology of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120292     DOI: 10.1196/annals.1447.031

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

2.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

3.  p204-Mediated innate antiviral responses in mouse adipose cells and their effects on cell functions.

Authors:  Lili Yu; Peng Liu; Zhenghui Liu; Weiwei Zhu; Keqin Yan; Qiaoyuan Chen; Daishu Han
Journal:  Immunol Cell Biol       Date:  2014-10-07       Impact factor: 5.126

4.  Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.

Authors:  Wilhem Leconet; Pierre Petit; Sylvie Peraldi-Roux; Damien Bresson
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

Review 5.  Type I interferon in organ-targeted autoimmune and inflammatory diseases.

Authors:  Mary K Crow
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

6.  Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as 'pregnancy-related' type 1 diabetes model.

Authors:  Akira Shimada; Kyoko Toda; Ikuo Inoue; Taketo Yamada; Yoichi Oikawa
Journal:  J Diabetes Investig       Date:  2022-05-26       Impact factor: 3.681

Review 7.  The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2016-03-24       Impact factor: 7.094

8.  Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes.

Authors:  Darshan Badal; Devi Dayal; Gunjan Singh; Naresh Sachdeva
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.